Tuesday's top analyst upgrades, downgrades and initiations include Alarm.com, Pandora Media, PayPal, SanDisk, SunEdison, Tesla Motors and Advanced Micro Devices.
A new research report from Cowen focuses on the top biotech stocks to buy before second-quarter earnings are reported.
Thursday's top analyst upgrades, downgrades and initiations include Apple, Envestnet, Pandora Media, Regeneron Pharmaceuticals, Spectra Energy and Travelers.
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of July and added some color.
There are still better ways to spend $666 than buying one share of a nosebleed stock with no dividend and a history of collapse on singular mistakes.
Monday's top analyst upgrades, downgrades and initiations include Exxon Mobil, Home Depot, Lululemon Athletica, 3M, Vodafone, Mondelez International and Chevron.
This coming week is likely to be a serious one in the fight against cholesterol. FDA panels are evaluating more than just one drug candidate.
S&P Capital IQ released a report regarding the performance of companies in terms of earnings and revenue.
There were some interesting positions of hedge funds in biotech, long and short, from the Goldman Sachs Hedge Fund Trend Monitor.
24/7 Wall St. has generated four earnings previews that investors will be watching closely in the week ahead.
A big part of the Nasdaq is biotech, and a new report from Cowen details the stocks that big money managers love and are staying with.
Tuesday's top analyst upgrades, downgrades and initiations from 24/7 Wall St. include American Express, Freescale Semiconductor, Micron Technology and Nordstrom.
Here are the five biotech stocks that are loved the most by portfolio managers, according to Cowen analysts.
Thursday's top analyst upgrades, downgrades and initiations seen from Wall Street research calls include Crocs, Halliburton, Nuance Communications, Staples and Yelp.
The continued strong insider buying last week into the teeth of a stock market that has hitting all-time highs continues to be a bullish sign for investors.
